Intelligence · Clinical Development
Pipeline search results
Programs matching “dupilumab” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 62 pipeline programs matching "dupilumab" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Dupilumab
Regeneron UK Limited
Lichen Simplex Chronicus
2 trials -
Dupilumab
Regeneron UK Limited
Eosinophilic Esophagitis (EoE)
2 trials -
Dupilumab
Regeneron UK Limited
Wheezing
1 trial -
Dupilumab
Regeneron UK Limited
Prurigo Nodularis
1 trial -
Dupilumab Prefilled Syringe
Regeneron UK Limited
Asthma Control
1 trial -
Dupilumab SAR231893
Regeneron UK Limited
Asthma
1 trial -
Dupilumab SAR231893
Regeneron UK Limited
Chronic Spontaneous Urticaria
1 trial -
Dupilumab SAR231893
Regeneron UK Limited
Chronic Rhinosinusitis Without Nasal Polyps
1 trial -
Dupilumab SAR231893
Regeneron UK Limited
Cold Urticaria
1 trial -
Dupilumab SAR231893
Regeneron UK Limited
Allergic Fungal Rhinosinusitis
1 trial -
Dupilumab SAR231893
Regeneron UK Limited
Neurodermatitis
2 trials -
Dupilumab SAR231893
Regeneron UK Limited
Chronic Obstructive Pulmonary Disease
2 trials -
Dupilumab SAR231893 (REGN668)
Regeneron UK Limited
Asthma
2 trials -
Dupilumab SAR231893 (REGN668)
Regeneron UK Limited
Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)
2 trials -
Dupilumab, Matched placebo for test product
Sanofi-aventis Healthcare Pty Ltd
Neurodermatitis
1 trial -
Dupilumab, Matched placebo for test product
Sanofi-aventis Healthcare Pty Ltd
Neurodermatitis
1 trial -
dupilumab
Regeneron UK Limited
Bullous Pemphigoid
1 trial -
dupilumab
Regeneron UK Limited
Moderate to Severe Atopic Hand and Foot Dermatitis
1 trial -
Dupilumab
Regeneron UK Limited
Asthma, Allergic
1 trial -
Dupilumab
Hospital Authority, Hong Kong
Nephrotic Syndrome in Children
1 trial -
Dupilumab
Regeneron UK Limited
Alopecia Areata
2 trials -
Dupilumab
Regeneron UK Limited
Allergies Food Milk
1 trial -
Dupilumab
Regeneron UK Limited
Peanut Allergy
2 trials -
Dupilumab
Regeneron UK Limited
Prostate Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.